ABMI - New Era? Good News .. Lets Start Fresh. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ABMI - New Era? Good News .. Lets Start Fresh.

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Greg Zielinski who wrote (20)	1/20/1998 10:29:00 AM
From: J. Malek Baroody	Read Replies (1) of 48

American BioMed <ABMI.OB> gets FDA OK for catheter WOODLANDS, Texas, Jan 20 (Reuters) - American BioMed Inc Tuesday said it received 510(k) market clearance from the U.S. Food and Drug Administration for a thrombectomy catheter to treat thromboemboli, the removal of clots from blood vessels. The product will be named the Ahn (dual balloon) thrombectomy catheter after Dr. Samuel Ahn, of the University of California at Los Angeles, who developed the product. The company expects to launch the product in the second quarter of 1998. The catheter incorporates a distal dual balloon design to more effectively remove emboli, as well as a proximal indicator safety balloon that allows the surgeon to visually determine inflation volume. A patent application has been filed with the U.S. Patent and Trademark Office for this product. American BioMed is a manufacturer of minimally invasive medical devices to treat cardiovascular disease. ((New York Newsdesk 212-859-1610)) REUTERS Copyright REUTER 10:11 01-20-98

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next